glycerophosphoinositol 4,5-bisphosphate has been researched along with Active Hyperemia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Gonzales, AL; Harraz, OF; Hill-Eubanks, D; Mughal, A; Nelson, MT | 1 |
Dabertrand, F; Harraz, OF; Hill-Eubanks, DC; Joutel, A; Koide, M; Longden, TA; Nelson, MT; Rosehart, AC | 1 |
Dent, MR; Dhalla, NS; Tappia, PS | 1 |
3 other study(ies) available for glycerophosphoinositol 4,5-bisphosphate and Active Hyperemia
Article | Year |
---|---|
PIP
Topics: Alzheimer Disease; Cerebrovascular Circulation; Endothelial Cells; Humans; Hyperemia; Phosphatidylinositol 4,5-Diphosphate | 2021 |
PIP
Topics: Animals; Cerebral Small Vessel Diseases; Cerebrovascular Circulation; Disease Models, Animal; Endothelial Cells; Hyperemia; Male; Mice, Transgenic; Phosphatidylinositol 4,5-Diphosphate; Potassium Channels, Inwardly Rectifying | 2021 |
Phospholipase C gene expression, protein content, and activities in cardiac hypertrophy and heart failure due to volume overload.
Topics: Animals; Cardiac Output, Low; Cardiomegaly; Cytosol; Diglycerides; Gene Expression; Hyperemia; Inositol 1,4,5-Trisphosphate; Isoenzymes; Male; Phosphatidylinositol 4,5-Diphosphate; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sarcolemma; Type C Phospholipases; Ventricular Function, Left | 2004 |